NCT05029271View on ClinicalTrials.gov

InPen User Experience

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

April 17, 2023

Primary Completion Date

December 8, 2023

Study Completion Date

December 8, 2023

Conditions
Diabetes Type 1
Interventions
DEVICE

InPen with Guardian 4 System

Subjects will receive the InPen™ and InPen™ Diabetes Management App combined with the Guardian™ 4 system.

Trial Locations (3)

Unknown

Örebro University Hospital, Örebro

NU-Hospital Group, Uddevalla

Frolunda specialist hospital, Västra Frölunda

All Listed Sponsors
lead

Medtronic Diabetes

INDUSTRY